Category Archives: Genetic medicine

Launched by British Prime Minister David Cameron on 28 July 2010 in Bangalore, India, Dishaa is an initiative that will expand, enrich and energise relations between India and the UK.

Dishaa means direction in India’s national language Hindi. And that what the it is aiming for direction for for future leaders from India and UK

Dishaa has announced the new challenge for the millenia will be

Heart surgery at $1,000 (USD) – what has to change in how society operates and innovates to make this a reality?

Dr Devi Shetty of  Narayana Hrudayalaya a large hospital group specializing in Cardiac Surgery from Bangalore, India says  it is on the way to become a reality

And he is going ahead with the plan to open India’s first low-cost hospital for caridac surgery will be up and running in Mysore  by early next year, to offer Cardiac Surgery at $1500 USD against the current cost of  $5000 USD in India

These state-of-the art hospitals will be built at a cost of  just $ 35 Million USD, about one-fifth the cost of constructing a 300-bed super-speciality hospital in India.  By 2012 Dr. Shetty plan to open 50 more such hospitals in India. the next are coming up in Siliguri (West Bengal) and Bhubaneswar (Orissa) with help from  The Union health ministry of India

Details on Dishaa page

http://www.commonpurpose.org/info/media-releases/101021_$1,000-(usd)-for-heart-surgery

Ah. well they should be protected, with the number of physicians unhappy with the Healthcare IT systems rising. We ll thank goodness patients will also get third party coverage if the software errs.

Chubb Group of Insurance Companies has established the “Healthcare Information Technology” liability insurance to protect Healthcare IT companies.

Over 1,000 companies supply information technology products and services to the healthcare and medical research industries in the US and Canada would be happy to hear that

An integrated liability solution from Chubb can help protect healthcare information technology companies from:

• general and products liability when software or hardware that is defective or contains inaccurate or incomplete information causes or contributes to patient injuries;
• errors and omission liability when a product defect or service deficiency results in economic injury to a customer;
• third-party liability to patients, healthcare providers and others associated with database security breaches; and
• costs incurred to comply with state, federal

Chubb is targeting Healthcare Information Technology Companies providing any of the following services

• Electronic health record system providers
• Clinical decision support system providers
• Telehealth and health information exchanges
• Practice management system providers
• Payor system providers
• Drug discovery firms
• Clinical informatics firms
• Healthcare systems consulting firms

Currently, 70% of Pharmaceutical organisations outsource at least one PV activity. This level is expected to increase to 80% by 2012.

Product marketing teams look at the software buying cycle as a consistent series of steps: awareness, consideration, trial, purchase, implementation and renewal.   For years, these steps have been manipulated through solution selling  where the key to success is control.  By knowing the buyer, the steps and the product, a skilled selling team is able to control the process and predict favorable outcomes on a consistent basis.  Oracle, SAP and Mic … Read More

via Inner Lining

GE Healthcare announced that the Smart Patient Room pilot at Bassett Medical Center has been approved by the site’s Institutional Review Board to begin data collection. The innovative technology solution was installed as part of GE’s healthymagination initiative with the goal of helping healthcare providers to reduce patient safety risks and improve patient outcomes.

“GE is developing a unique solution for the healthcare industry that helps hospitals and staff identify and mitigate patient safety risks while offering meaningful solutions to improve patient outcomes,” said Jan De Witte, President & CEO, GE Healthcare Performance Solutions. “GE’s real-time, adaptable solution will provide actionable data to healthcare providers regarding patient safety and potential medical errors which in turn will affect the necessary behavioral changes to avoid preventable errors.”

The Smart Patient Room can collect real-time information from the system to generate actionable data to manage clinical workflow, and uncover opportunities for influencing process and behavioral changes to create a safer patient environment.

developers at Mount Sinai develop a New database and software, called ChEA which can speed up drug discovery at Mount Sinai develop a New database and software, called ChEA which can speed up drug discovery

The ChEA software and ChIP-X database is freely available online at:http://amp.pharm.mssm.edu/lib/chea.jsp.

until ChEA was developed, no centralized database integrated results from, for instance, ChIP-seq and ChIP-chip experiments (these are used to identify how “transcription factor” proteins might regulate all genes in humans and mice). Now this new computational method should help streamline how scientists analyze these gene expression experiments

Single patient Clinical Trial are not new idea, FDA did not focus since such trial canot prove the efficacy and safety of medicine over a large pool of patient with sufficient data. But I was forced to re-think after reading the article http://www.technologyreview.in/biomedicine/12537/ why cant we use the the concept mentioned in to overcome the ethical and other challenges in current mode of trials.

So I decided to ask the question to the linkedin audience http://www.linkedin.com/answers/technology/biotech/TCH_BIO/667022-9262868?browseIdx=0&sik=1272969161323&goback=.amq

Single patient Clinical Trial are not new idea, FDA did not focus since such trial canot prove the efficacy and safety of medicine over a large pool of patient with sufficient data. But I was forced to re-think after reading the article http://www.technologyreview.in/biomedicine/12537/ why cant we use the the concept mentioned in to overcome the ethical and other challenges in current mode of trials.

So I decided to ask the question to the linkedin audience http://www.linkedin.com/answers/technology/biotech/TCH_BIO/667022-9262868?browseIdx=0&sik=1272969161323&goback=.amq